Skip to content
10-Q

Quarterly Report

Sana Biotechnology, Inc. SANA

0001193125-25-269569

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 29, 2025 266.37M sh
Shares Diluted Q3 2025 · Sep 30, 2025 260.49M sh
Shares Diluted Q3 2025 · Sep 30, 2025 245.58M sh
Shares Diluted Q3 2025 · Sep 30, 2024 235.41M sh
Shares Diluted Q3 2025 · Sep 30, 2024 229.08M sh
Capex Q3 2025 · Sep 30, 2025 $65K
Capex Q3 2025 · Sep 30, 2024 $32.99M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$111.19M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$175.99M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $103.36M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $127.57M
Stockholders Equity Q3 2025 · Sep 30, 2025 $195.31M
Stockholders Equity Q3 2025 · Jun 30, 2025 $122.56M
Stockholders Equity Q3 2025 · Mar 31, 2025 $209.08M
Stockholders Equity Q3 2025 · Dec 31, 2024 $250.5M
Stockholders Equity Q3 2025 · Sep 30, 2024 $292.48M
Stockholders Equity Q3 2025 · Jun 30, 2024 $339.65M
Stockholders Equity Q3 2025 · Mar 31, 2024 $375.14M
Stockholders Equity Q3 2025 · Dec 31, 2023 $287.51M
Current Liabilities Q3 2025 · Sep 30, 2025 $35.51M
Current Liabilities Q3 2025 · Dec 31, 2024 $45.43M
Total Liabilities Q3 2025 · Sep 30, 2025 $240.12M
Total Liabilities Q3 2025 · Dec 31, 2024 $250.52M
Current Assets Q3 2025 · Sep 30, 2025 $161.76M
Current Assets Q3 2025 · Dec 31, 2024 $160.81M
Total Assets Q3 2025 · Sep 30, 2025 $435.43M
Total Assets Q3 2025 · Dec 31, 2024 $501.02M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.16
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.75
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.25
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.95
Eps Basic Q3 2025 · Sep 30, 2025 −$0.16
Eps Basic Q3 2025 · Sep 30, 2025 −$0.75
Eps Basic Q3 2025 · Sep 30, 2024 −$0.25
Eps Basic Q3 2025 · Sep 30, 2024 −$0.95
Sga Expense Q3 2025 · Sep 30, 2025 $10.29M
Sga Expense Q3 2025 · Sep 30, 2025 $32.11M
Sga Expense Q3 2025 · Sep 30, 2024 $14.05M
Sga Expense Q3 2025 · Sep 30, 2024 $46.76M
Rd Expense Q3 2025 · Sep 30, 2025 $30.11M
Rd Expense Q3 2025 · Sep 30, 2025 $97.06M
Rd Expense Q3 2025 · Sep 30, 2024 $53.21M
Rd Expense Q3 2025 · Sep 30, 2024 $170.53M
Net Income Q3 2025 · Sep 30, 2025 −$42.15M
Net Income Q3 2025 · Sep 30, 2025 −$185.34M
Net Income Q3 2025 · Jun 30, 2025 −$93.8M
Net Income Q3 2025 · Mar 31, 2025 −$49.39M
Net Income Q3 2025 · Sep 30, 2024 −$59.92M
Net Income Q3 2025 · Sep 30, 2024 −$217.69M
Net Income Q3 2025 · Jun 30, 2024 −$50.29M
Net Income Q3 2025 · Mar 31, 2024 −$107.48M
Operating Income Q3 2025 · Sep 30, 2025 −$43.52M
Operating Income Q3 2025 · Sep 30, 2025 −$189.12M
Operating Income Q3 2025 · Sep 30, 2024 −$61.76M
Operating Income Q3 2025 · Sep 30, 2024 −$221.86M